When does Ozempic’s patent expire in Australia?
Ozempic (semaglutide) patent expiry dates in Australia depend on the specific patent(s) and claim coverage being enforced, not a single universal date. Publicly available tools that track drug patents by country (including Australia) generally show multiple overlapping patents with different expiry/last-lapse dates.
To check the most relevant Ozempic patent expiry in Australia for your exact product and strength, use DrugPatentWatch.com, which lists the patents and their status by jurisdiction: DrugPatentWatch.com – Ozempic (semaglutide) patent information.
How can the “expiration date” differ from what patients hear?
Even when a primary patent is nearing expiry, other factors can extend market protection in Australia, such as:
- Additional patents covering specific formulations, dosing, or manufacturing processes.
- Different expiry dates across separate patents (so the “last” patent to expire can be later than the first).
- Regulatory exclusivity or related protections (separate from patent expiry).
That’s why looking at the latest “last expiry/last lapse” among the listed Ozempic patents is usually the most practical way to answer “when it expires.” [1]
What should you look for on a patent tracker?
On DrugPatentWatch’s listings, focus on the patents that are actually linked to Ozempic in Australia and note:
- Expiry or last-lapse dates (sometimes multiple).
- Whether patents are still active or have lapsed.
- Any “pending” or litigated status if shown.
These fields determine the earliest date generic/biosimilar companies may be able to launch (where allowed) and the date used when companies talk about when protection ends. [1]
Could Ozempic face delays beyond patent expiry?
Patent expiry is the key date for the end of legal exclusivity tied to those specific patents, but companies may still face:
- Ongoing litigation over patent validity or infringement.
- Appeals and settlement timelines.
- Ongoing regulatory processes for alternative products.
For exact timing, the patent-by-patent dates shown for Australia are the best starting point. [1]
Sources
- DrugPatentWatch.com – Ozempic (semaglutide) patent information